Our mission is to develop innovative diagnostic products with advanced technologies in early warning and early diagnoses of major human diseases. Tarcine is committed to improving human health.

The 21st century has become the era for Biotechnology. As a result, in vitro diagnostic technologies and services are expanding rapidly. In vitro diagnostic industry has become crucial in prevention and early diagnoses of diseases, determination of drug efficacy and prognosis, drug treatment monitoring, evaluations of health status and personalized treatment. With the development of global economy and healthcare industry, in vitro diagnostic industry has become the  active industries.

Taking advantage of tremendous growth opportunities in today’s IVD industry, Tarcine BioMed focuses on providing novel diagnostic products for unmet medical needs. Tarcine collaborates with partners to develop and offer multiple product lines based on a broad range of technology platforms. Tarcine BioMed strives to become an innovative molecular diagnostic company with full capabilities in R&D, manufacturing and sales & marketing.